Filing Flows › Comparisons › TGTX vs AXSM
TG Therapeutics vs Axsome Therapeutics: TGTX and AXSM compared
TG Therapeutics is the larger company: $260M of revenue in its latest quarter (Q3 2026) against $260M for Axsome Therapeutics (Q3 2026). TG Therapeutics is growing faster (+61% against +52% a year earlier). TG Therapeutics is more profitable, with an operating margin of 33.0% against -4.3%.
Where the money goes: TGTX and AXSM
TG Therapeutics (TGTX) · Q3 2026
TG Therapeutics, Q3 2026: revenue $260M (+61% year over year), operating margin 33.0%, net earnings $55.5M. The chart follows the revenue to costs, profit and cash.
Axsome Therapeutics (AXSM) · Q3 2026
Axsome Therapeutics, Q3 2026: revenue $260M (+52% year over year), operating margin -4.3%, net loss $12.9M, operating cash flow −$9.5M. The chart follows the revenue to costs, profit and cash.
| TG Therapeutics (TGTX) | Axsome Therapeutics (AXSM) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $260M | $260M |
| Revenue growth, Y/Y | +61% | +52% |
| Operating margin | 33.0% | -4.3% |
| Net earnings | $55.5M | −$12.9M |
| Net margin | 21.3% | -5.0% |
| Operating cash flow | — | −$9.5M |
| Market value | $8.7B | $8.8B |
| P/E | 19.7× | — |
| Analysts’ mean target | $69.71 | $265.86 |
Where the revenue comes from
TG Therapeutics
- Product revenue, net: $240M (92%)
- License, milestone, royalty and other revenue: $19.9M (8%)
Axsome Therapeutics
- Product: $250M (96%)
- Royalty and Milestone Revenue: $9.7M (4%)
Questions
Which is bigger, TG Therapeutics or Axsome Therapeutics?
TG Therapeutics is the larger company: $260M of revenue in its latest quarter (Q3 2026) against $260M for Axsome Therapeutics (Q3 2026).
Is TG Therapeutics or Axsome Therapeutics growing faster?
TG Therapeutics is growing faster (+61% against +52% a year earlier).
Which is more profitable, TG Therapeutics or Axsome Therapeutics?
TG Therapeutics is more profitable, with an operating margin of 33.0% against -4.3%.
More: TG Therapeutics earnings · how TG Therapeutics makes money · Axsome Therapeutics earnings · how Axsome Therapeutics makes money
From the companies' latest 10-Q, 10-K or earnings release (8-K filed Nov 9, 2026; 10-Q filed Nov 2, 2026). Fiscal quarters can end on different dates. Not investment advice.